Study title: AN 07416909 Medline 20070101. TI Effects of cyproheptadine on symptoms and attitudes in anorexia nervosa. SO Archives of general psychiatry, {Arch-Gen-Psychiatry}, Sep 1980, vol. 37, no. 9, p. 1083, ISSN: 0003-990X. AU Goldberg-S-C, Eckert-E-D, Halmi-K-A, Casper-R-C, Davis-J-M, Roper-M. YR 1980.AN 07416909 Medline 20070101. TI Effects of cyproheptadine on symptoms and attitudes in anorexia nervosa. SO Archives of general psychiatry, {Arch-Gen-Psychiatry}, Sep 1980, vol. 37, no. 9, p. 1083, ISSN: 0003-990X. AU Goldberg-S-C, Eckert-E-D, Halmi-K-A, Casper-R-C, Davis-J-M, Roper-M. YR 1980.
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Endocrine System Diseases [C19] | |||||
| Brands: Please see report, Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: CYPROHEPTADINE | |||||
| ATC code: | |||||
| Document link: | |||||
| Document date: | |||||
| Study number: | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | - | |